RICTOR and invasive breast carcinoma: RICTOR being a key component of mTORC2, earlier studies on the analysis of The Cancer Genome Atlas (TCGA) curated invasive breast carcinoma patient datasets showed a significant correlation of RICTOR upregulation, mutation, or amplification with low overall survival [29,30].